GLP-1 expression has been observed in breast cancer, where it influences not only the increase in cAMP levels and activation of CREB, but also the activation of GLP-1 and the inhibition of NF-kβ activation, leading to inhibited proliferation of breast cancer cells [37,38,39,40]. Here, NFKB1 is linked to breast carcinoma.